Provided by Tiger Fintech (Singapore) Pte. Ltd.

Legend Biotech

39.59
+0.15000.38%
Pre-market: 39.780.1900+0.48%06:31 EDT
Volume:1.95M
Turnover:76.87M
Market Cap:7.30B
PE:-33.26
High:40.43
Open:39.63
Low:38.53
Close:39.44
Loading ...

Legend Biotech Price Target Maintained With a $75.00/Share by HC Wainwright & Co.

Dow Jones
·
08 Apr

RBC Capital Keeps Their Buy Rating on Legend Biotech (LEGN)

TIPRANKS
·
05 Apr

Biotech stocks slide as Marks resignation seen being negative for sector

TipRanks
·
01 Apr

Legend Biotech Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
18 Mar

Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN) and EyePoint Pharmaceuticals (EYPT)

TIPRANKS
·
17 Mar

Legend Biotech (LEGN) Blockbuster Fuels Expectation-beating Growth

TIPRANKS
·
13 Mar

William Blair Sticks to Their Hold Rating for Legend Biotech (LEGN)

TIPRANKS
·
12 Mar

Legend Biotech Corp (LEGN) Q4 2024 Earnings Call Highlights: Record CARVYKTI Sales and ...

GuruFocus.com
·
12 Mar

Q4 2024 Legend Biotech Corp Earnings Call

Thomson Reuters StreetEvents
·
12 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Elevance, Backblaze, Disney

Reuters
·
12 Mar

Genscript Biotech Announces Legend Biotech’s 2024 Financial Results

TIPRANKS
·
11 Mar

BUZZ-Legend Biotech gains on narrower Q4 loss

Reuters
·
11 Mar

Compared to Estimates, Legend Biotech (LEGN) Q4 Earnings: A Look at Key Metrics

Zacks
·
11 Mar

Sector Update: Health Care Stocks Mixed Premarket Tuesday

MT Newswires Live
·
11 Mar

Legend Biotech's Q4 Net Loss Narrows, Revenue Rises

MT Newswires Live
·
11 Mar

Legend Biotech Q4 2024 Adj EPS $(0.16) Beats $(0.33) Estimate, Sales $186.52M Beat $178.93M Estimate

Benzinga
·
11 Mar

Earnings Flash (LEGN) Legend Biotech Posts Q4 EPS $0.07 a Share, vs. FactSet Est of $-0.23 Loss

MT Newswires Live
·
11 Mar

Legend Biotech Reports Fourth Quarter and Full Year 2024 Results and Recent Highlights

GlobeNewswire
·
11 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
11 Mar

Legend Biotech Corp expected to post a loss of 33 cents a share - Earnings Preview

Reuters
·
07 Mar